RECRUITING

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Description

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Conditions

Lung CarcinomaMetastatic Malignant Neoplasm in the Lung
Talk to us

Related Conditions:

Lung CarcinomaMetastatic Malignant Neoplasm in the Lung

Study Overview

On this page

Study Details

Study overview

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Condition
Lung Carcinoma
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \* Subject age 18 years and older
  • * Subject is scheduled for a bronchoscopy as part of standard of care
  • * Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
  • * Ability to provide blood or saliva sample
  • * Enrolled in study IRB#16-009655
  • * Ability to provide archived tissue
  • * Subject is able to understand and adhere to study requirements and able to provide informed consent
  • * \* Individuals who have situations that would limit compliance with the study requirements
  • * Institutionalized (i.e. federal medical prison)
  • * Pregnant
  • * Prior germline genetic testing with a 40+ multi-gene panel within the last 1 year of enrollment
  • * Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Janani S. Reisenauer, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

2027-07-01